At a glance
ClinicalIndex Comparison RecordN/ACompleted· 219 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patient Registry of Intrathecal Pain Management in Europe: An Open-label, Long-term, Multi-center, Multi-national Post-marketing Observational Study of the Use of Prialt (Ziconotide Intrathecal Infusion) and Alternative Drugs for the Management of Severe, Chronic Pain.
In Brief
An observational study for Pain Management and Severe Chronic Pain. Completed, enrolled 219 participants.
Detailed Summary
This is an open-label, long-term, multi-center multi-national post-marketing observational registry. The objective of this study is to monitor the long-term efficacy, safety, tolerability and quality of life outcomes associated with ziconotide (Prialt) and other analgesics utilized in the intrathecal (IT) management of severe chronic pain.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain Management, Severe Chronic Pain
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
Primary CompletionJul 2012
First PostedOct 2014
TodayJul 2026
First PostedOct 20, 2014
Enrollment StartApr 1, 2008
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 11.7 years ago